Patients with depression tend to smoke a lot, which led to the idea that nicotine may ease depressive symptoms. Research has shown how the process works. Nicotine binds to particular receptor molecules on the surface of...
Next Generation Therapies
Marina R. Picciotto, Ph.D.
December 17, 2012
Christine I. Hooker, Ph.D.
December 17, 2012
Schizophrenia-associated deficits in cognition are not substantially improved by medication, but have been shown to improve with remedial cognitive training. The mechanisms that support this improvement have been largely...
Karl Deisseroth, M.D., Ph.D.
December 12, 2012
A team of neuroscientists led by NARSAD Young Investigator Grantee and Scientific Council Member Karl Deisseroth, M.D., Ph.D., has demonstrated for the first time how dopamine neurons are linked to depression. The team at...
Carmine M. Pariante, M.D., Ph.D.
December 11, 2012
Carmine M. Pariante, M.D., Ph.D., Professor of Biological Psychiatry at King’s College London’s Institute of Psychiatry, is one of the authors of a new study that identifies the signaling pathway in the brain that, when...
Steven Laviolette, Ph.D.
December 06, 2012
Research being done in the laboratory of NARSAD Young Investigator Grantee Steven Laviolette, Ph.D. has revealed a way to suppress memories that may lead to new treatments for both Post-Traumatic Stress Disorder (PTSD)...
Pages
